General Information of the Cell Line
Cell Line ID
CL000438
Cell Line Name
A-172
Synonyms
A172
A 172
A-172 MG
A-172MG
Category
Cancer cell line
Organism
Homo sapiens (Human)
Cellosaurus ID
CVCL_0131
Tissue Information
Brain
Disease
Glioblastoma (NCIt: C3058)
Glioblastoma (ORDO: Orphanet_360)
Map of Molecular Bioactivity Related to the Cell Line
Map of Molecular Bioactivity Related to the Cell Line

Cell Line
Protein
Compound

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Cell Line
Protein ID: PT01557, Indoleamine 2,3-dioxygenase 1
Compound ID Compound Name Compound Formula
CP0564188
(1S)-1-cyclohexyl-2-[(5S)-5H-imidazo[5,1-a]isoindol-5-yl]ethanol
   Show/Hide
C18H22N2O
 1
1
EC50 = 130 nM
   TI
   LI
   LO
   TS
CP0238103
(1S,2S)-2-[(5S)-5H-imidazo[5,1-a]isoindol-5-yl]-1,2,3,4-tetrahydronaphthalen-1-ol
   Show/Hide
C20H18N2O
 1
1
EC50 = 240 nM
   TI
   LI
   LO
   TS
CP0552205
(5S)-5-cyclohexyl-5H-imidazo[5,1-a]isoindole
   Show/Hide
C16H18N2
 1
1
EC50 = 420 nM
   TI
   LI
   LO
   TS
CP0519131
(1R,2S)-1-cyclohexyl-2-[(5S)-5H-imidazo[5,1-a]isoindol-5-yl]propan-1-ol
   Show/Hide
C19H24N2O
 1
1
EC50 = 670 nM
   TI
   LI
   LO
   TS
CP0387082
(7S,8S)-8-hydroxy-7-[(5S)-5H-imidazo[5,1-a]isoindol-5-yl]-5,6,7,8-tetrahydronaphthalene-2-carbonitrile
   Show/Hide
C21H17N3O
 1
1
EC50 = 690 nM
   TI
   LI
   LO
   TS
CP0438720
(1R,2S)-2-[(5S)-5H-imidazo[5,1-a]isoindol-5-yl]cyclohexan-1-ol
   Show/Hide
C16H18N2O
 1
1
EC50 = 720 nM
   TI
   LI
   LO
   TS
CP0537143
(5S,6S)-6-[(5S)-5H-imidazo[5,1-a]isoindol-5-yl]-5,6,7,8-tetrahydroisoquinolin-5-ol
   Show/Hide
C19H17N3O
 1
1
EC50 = 800 nM
   TI
   LI
   LO
   TS
CP0387094
(1S,2S)-2-[(5S)-5H-imidazo[5,1-a]isoindol-5-yl]-7-methylsulfonyl-1,2,3,4-tetrahydronaphthalen-1-ol
   Show/Hide
C21H20N2O3S
 1
1
EC50 = 880 nM
   TI
   LI
   LO
   TS
CP0165568
(3S,4S)-4-[(5S)-5H-imidazo[5,1-a]isoindol-5-yl]-1-methylsulfonylpiperidin-3-ol
   Show/Hide
C16H19N3O3S
 1
1
EC50 = 970 nM
   TI
   LI
   LO
   TS
CP0462096
(1S,2S)-2-[(5S)-5H-imidazo[5,1-a]isoindol-5-yl]-6-methylsulfonyl-1,2,3,4-tetrahydronaphthalen-1-ol
   Show/Hide
C21H20N2O3S
 1
1
EC50 = 1300 nM
   TI
   LI
   LO
   TS
CP0394145
(7S,8S)-7-[(5S)-5H-imidazo[5,1-a]isoindol-5-yl]-5,6,7,8-tetrahydroisoquinolin-8-ol
   Show/Hide
C19H17N3O
 1
1
EC50 = 1400 nM
   TI
   LI
   LO
   TS
CP0476298
(1R,2S)-2-[(5S)-5H-imidazo[5,1-a]isoindol-5-yl]cyclobutan-1-ol
   Show/Hide
C14H14N2O
 1
1
EC50 = 1400 nM
   TI
   LI
   LO
   TS
CP0165569
(3S,4S)-4-[(5S)-5H-imidazo[5,1-a]isoindol-5-yl]oxan-3-ol
   Show/Hide
C15H16N2O2
 1
1
EC50 = 1600 nM
   TI
   LI
   LO
   TS
CP0482242
(1R,2S)-2-[(5S)-5H-imidazo[5,1-a]isoindol-5-yl]cyclopentan-1-ol
   Show/Hide
C15H16N2O
 1
1
EC50 = 2200 nM
   TI
   LI
   LO
   TS
CP0225409
(7S,8S)-8-hydroxy-7-[(5S)-5H-imidazo[5,1-a]isoindol-5-yl]-5,6,7,8-tetrahydronaphthalene-2-carboxamide
   Show/Hide
C21H19N3O2
 1
1
EC50 = 2600 nM
   TI
   LI
   LO
   TS
CP0519130
(3R,4R)-3-[(5S)-5H-imidazo[5,1-a]isoindol-5-yl]oxan-4-ol
   Show/Hide
C15H16N2O2
 1
1
EC50 = 2900 nM
   TI
   LI
   LO
   TS
CP0230210
(4S,5S)-5-[(5S)-5H-imidazo[5,1-a]isoindol-5-yl]-4,5,6,7-tetrahydropyrazolo[1,5-a]pyridin-4-ol
   Show/Hide
C17H16N4O
 1
1
EC50 = 4500 nM
   TI
   LI
   LO
   TS
CP0165570
(4S,5S)-5-[(5S)-5H-imidazo[5,1-a]isoindol-5-yl]-4,5,6,7-tetrahydro-2,1,3-benzoxadiazol-4-ol
   Show/Hide
C16H14N4O2
 1
1
EC50 = 4600 nM
   TI
   LI
   LO
   TS
CP0327837
(1S,2S)-7-dimethylphosphoryl-2-[(5S)-5H-imidazo[5,1-a]isoindol-5-yl]-1,2,3,4-tetrahydronaphthalen-1-ol
   Show/Hide
C22H23N2O2P
 1
1
EC50 = 10000 nM
   TI
   LI
   LO
   TS
CP0519132
(4S,5S)-5-[(5S)-5H-imidazo[5,1-a]isoindol-5-yl]-1-methyl-4,5,6,7-tetrahydroindazol-4-ol
   Show/Hide
C18H18N4O
 1
1
EC50 = 13000 nM
   TI
   LI
   LO
   TS
CP0537144
(3S,4S)-4-[(5S)-5H-imidazo[5,1-a]isoindol-5-yl]-1-methylpiperidin-3-ol
   Show/Hide
C16H19N3O
 1
1
EC50 = 20000 nM
   TI
   LI
   LO
   TS
CP0387095
1-[(3S,4S)-3-hydroxy-4-[(5S)-5H-imidazo[5,1-a]isoindol-5-yl]piperidin-1-yl]ethanone
   Show/Hide
C17H19N3O2
 1
1
EC50 > 25000 nM
   TI
   LI
   LO
   TS
CP0394144
(7S,8S)-7-[(5S)-5H-imidazo[5,1-a]isoindol-5-yl]-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyridin-8-ol
   Show/Hide
C16H15N5O
 1
1
EC50 > 25000 nM
   TI
   LI
   LO
   TS
Cell Viability or Cytotoxicity Assay
Compound ID Compound Name Compound Formula
CP0140704
2-[[5-chloro-2-[4-[[[3,4-dioxo-2-[2-(prop-2-enoylamino)ethylamino]cyclobuten-1-yl]amino]methyl]anilino]pyrimidin-4-yl]amino]-N-methylbenzamide
   Show/Hide
C28H27ClN8O4  1
1
IC50 = 650 nM
   TI
   LI
   LO
   TS
CP0154554
[4-(1-methylimidazole-4-carbonyl)piperazin-1-yl]-[4-(tetrazolo[1,5-a]quinoxalin-4-ylamino)phenyl]methanone
   Show/Hide
C24H22N10O2  1
1
GI50 = 3162.28 nM
   TI
   LI
   LO
   TS
CP0424792
2-[[5-chloro-2-[4-[[[2-[2-[[(E)-2-cyano-3-cyclopropylprop-2-enoyl]amino]ethylamino]-3,4-dioxocyclobuten-1-yl]amino]methyl]anilino]pyrimidin-4-yl]amino]-N-methylbenzamide
   Show/Hide
C32H30ClN9O4  1
1
IC50 = 890 nM
   TI
   LI
   LO
   TS
CP0725696
N-[3-(2,5-Dimethoxybenzyloxy)-4-(methanesulfonylamino)-phenyl]-4-methoxybenzamide
   Show/Hide
C24H26N2O7S  1
1
IC50 = 6.24 nM
   TI
   LI
   LO
   TS
Protein family and CMB statistics Related to the Cell Line
Cell Lines Derived from the same Tissue Source (Brain)
Cell Line Name Organism Disease
TS603 Homo sapiens (Human) Anaplastic oligodendroglioma
H4 Homo sapiens (Human) Astrocytoma
1321N1 Homo sapiens (Human) Astrocytoma
SNB-19 Homo sapiens (Human) Astrocytoma
U-251MG Homo sapiens (Human) Astrocytoma
U-373MG ATCC Homo sapiens (Human) Astrocytoma
LN-308 Homo sapiens (Human) Astrocytoma
CCF-STTG1 Homo sapiens (Human) Astrocytoma
LN-319 Homo sapiens (Human) Astrocytoma
P2X7-1321N1 Homo sapiens (Human) Astrocytoma
MDA-MB-361 Homo sapiens (Human) Breast adenocarcinoma
JEG-3 Homo sapiens (Human) Gestational choriocarcinoma
D3 [Human glioblastoma] Homo sapiens (Human) Glioblastoma
LN-229 Homo sapiens (Human) Glioblastoma
LN-18 Homo sapiens (Human) Glioblastoma
UC-11MG Homo sapiens (Human) Glioblastoma
T98G Homo sapiens (Human) Glioblastoma
LN229-V6R Homo sapiens (Human) Glioblastoma
SF539 Homo sapiens (Human) Gliosarcoma
MED1 Homo sapiens (Human) Medulloblastoma, non-WNT/non-SHH, group 4
Kelly Homo sapiens (Human) Neuroblastoma
PFSK-1 Homo sapiens (Human) Primitive neuroectodermal tumor
DU145 Homo sapiens (Human) Prostate carcinoma
DU145-TxR Homo sapiens (Human) Prostate carcinoma
GL261 Mus musculus (Mouse) Mouse glioblastoma
C6 Rattus norvegicus (Rat) Rat malignant glioma
C6-BU-1 Rattus norvegicus (Rat) Rat malignant glioma
RG2 Rattus norvegicus (Rat) Rat malignant glioma
ReNcell VM Homo sapiens (Human) -
hCMEC/D3 Homo sapiens (Human) -
BV-2 Mus musculus (Mouse) -
C17.2 Mus musculus (Mouse) -
ScGT1 Mus musculus (Mouse) -
bEnd.4 Mus musculus (Mouse) -
N39 Mus musculus (Mouse) -
GT1-7 Mus musculus (Mouse) -
N27-A Rattus norvegicus (Rat) -
RBE4 Rattus norvegicus (Rat) -